Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
Kazia Therapeutics股票下跌，因FDA阻碍潜在脑癌药物的快速通道。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间